S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Better Than Oil Stocks (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Elon Bets Big On Controversial Energy Tech: "This Is Bigger Than AI" (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
This Stock Could Go Up 66% or More. (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Better Than Oil Stocks (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Elon Bets Big On Controversial Energy Tech: "This Is Bigger Than AI" (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
This Stock Could Go Up 66% or More. (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Better Than Oil Stocks (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Elon Bets Big On Controversial Energy Tech: "This Is Bigger Than AI" (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
This Stock Could Go Up 66% or More. (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Better Than Oil Stocks (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Elon Bets Big On Controversial Energy Tech: "This Is Bigger Than AI" (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
This Stock Could Go Up 66% or More. (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
OTCMKTS:INNVD

Innovus Pharmaceuticals (INNVD) News Today

Compare
Today's Range
N/A
50-Day Range
$3.00
$3.00
52-Week Range
N/A
Volume
4,300 shs
Average Volume
9,592 shs
Market Capitalization
$7.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SourceHeadline
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Maravai Lifesciences Holdings (MRVI)
markets.businessinsider.com - September 27 at 7:57 AM
reuters.com logoNovartis names new board member after international boss steps down
reuters.com - September 6 at 2:23 AM
markets.businessinsider.com logoWhere Olema Pharmaceuticals Stands With Analysts
markets.businessinsider.com - September 5 at 4:04 PM
marketwatch.com logoInovio Pharmaceuticals Inc. stock falls Tuesday, underperforms market
marketwatch.com - August 15 at 5:50 PM
markets.businessinsider.com logoInovio Pharmaceuticals Inc. Q2 Loss decreases, beats estimates
markets.businessinsider.com - August 9 at 6:00 PM
msn.com logoOppenheimer Maintains Regeneron Pharmaceuticals (REGN) Outperform Recommendation
msn.com - August 4 at 3:26 PM
bizjournals.com logoBaltimore cannabis pharmaceutical company plans to go public on Nasdaq
bizjournals.com - July 25 at 4:05 PM
benzinga.com logoSupernus Pharmaceuticals Entered Into Settlement And License Agreements With Apotex Inc. And Apotex Corp On June 21
benzinga.com - June 23 at 6:38 PM
finance.yahoo.com logoCosette Pharmaceuticals Acquires Intrarosa® from Endoceutics, Inc.
finance.yahoo.com - June 17 at 6:03 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Cigna (CI) and Jazz Pharmaceuticals (JAZZ)
markets.businessinsider.com - June 9 at 7:12 AM
fool.com logoBioMarin Pharmaceutical (NASDAQ: BMRN)
fool.com - June 4 at 3:08 PM
wsj.com logoRafarma Pharmaceuticals Inc.
wsj.com - May 18 at 10:34 PM
seekingalpha.com logoAmylyx Pharmaceuticals, Inc. (AMLX) Q1 2023 Earnings Call Transcript
seekingalpha.com - May 17 at 12:14 AM
markets.businessinsider.com logoHere's what to expect from Imprimis Pharmaceuticals's earnings report
markets.businessinsider.com - May 10 at 12:36 PM
msn.com logoSamsung head seeks ties with global pharmaceutical firms
msn.com - May 7 at 12:37 PM
marketwatch.com logo2023 Sea Salt Nasal Spray Market Challenges : New Business Opportunities in Grooming Regions
marketwatch.com - April 28 at 11:24 PM
finance.yahoo.com logoNavco Pharmaceuticals Inc. Announces Closing of Qualifying Transaction
finance.yahoo.com - April 19 at 10:33 AM
marketwatch.com logoHome Diagnostics for Urinary Tract Infection Market Facts and Figures By 2030
marketwatch.com - April 18 at 11:50 PM
seekingalpha.com logoPieris Pharmaceuticals, Inc. (PIRS) Q4 2022 Earnings Call Transcript
seekingalpha.com - March 31 at 10:08 AM
marketwatch.com logoHome Diagnostics for Urinary Tract Infection Market Size, Share, Forecast and Outlook to 2030
marketwatch.com - March 31 at 10:08 AM
seekingalpha.com logoAcumen Pharmaceuticals, Inc. 2022 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 29 at 5:57 PM
marketwatch.com logoSea Salt Nasal Spray Market Key Players and Forecast till 2031
marketwatch.com - March 24 at 6:15 PM
marketwatch.com logo2023-2029 Premature Ejaculation Treatment Drug Market Size and Market Dynamic Analysis | Latest Report by Absolute Reports
marketwatch.com - March 23 at 2:58 PM
marketwatch.com logoInovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
marketwatch.com - March 16 at 8:57 PM
seekingalpha.com logoMIST
seekingalpha.com - March 15 at 7:14 AM
marketwatch.com logoHome Diagnostics for Urinary Tract Infection Market Forecast 2023-2028: Expert Analysis on Emerging Trends and Future Innovations
marketwatch.com - March 14 at 4:12 PM
nasdaq.com logoGuru Fundamental Report for REGENERON PHARMACEUTICALS INC - Dashan Huang
nasdaq.com - March 10 at 9:50 PM
seekingalpha.com logoEyePoint Pharmaceuticals, Inc. (EYPT) Q4 2022 Earnings Call Transcript
seekingalpha.com - March 4 at 4:13 PM
markets.businessinsider.com logoInovio Pharmaceuticals Inc. Q4 Loss decreases, but misses estimates
markets.businessinsider.com - March 1 at 5:12 PM
finance.yahoo.com logoRegeneron Pharmaceuticals, Inc.: Raising target to $825
finance.yahoo.com - February 24 at 1:43 PM
msn.com logoInfinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge
msn.com - February 23 at 3:39 PM
marketwatch.com logoMEI Pharma to Buy Infinity Pharmaceuticals in All-Stock Deal
marketwatch.com - February 23 at 10:12 AM
marketwatch.com logoHome Diagnostics for Urinary Tract Infection Market [360 Market Updates] Reports Development Expenditure and Financial Insights 2028
marketwatch.com - February 17 at 1:27 PM
benzinga.com logoZynerba Pharmaceuticals Stock (NASDAQ:ZYNE), Quotes and News Summary
benzinga.com - February 11 at 11:20 PM
marketwatch.com logoSea Salt Nasal Spray Market Analysis by Size, Share Trends, Qualitative Outlook and Global Forecast to 2029
marketwatch.com - February 7 at 11:24 PM
seekingalpha.com logoACXP Acurx Pharmaceuticals, Inc.
seekingalpha.com - January 26 at 10:20 AM
benzinga.com logoPharmaceutical Packaging Equipment Market Worth $8.69 Billion By 2030: Grand View Research, Inc.
benzinga.com - January 25 at 12:59 PM
marketwatch.com logoInovio Pharmaceuticals Inc. stock rises Tuesday, outperforms market
marketwatch.com - January 24 at 5:56 PM
benzinga.com logoKonsyl Pharmaceuticals, Inc. Launches Four New Gut Health Fiber Gummies
benzinga.com - January 22 at 8:18 AM
benzinga.com logoTimber Pharmaceuticals Stock (AMEX:TMBR), Quotes and News Summary
benzinga.com - January 13 at 3:38 PM
markets.businessinsider.com logoBioCryst Pharmaceuticals Stock Is Tumbling: What's Going On?
markets.businessinsider.com - January 9 at 11:11 AM
marketwatch.com logoAurinia Pharmaceuticals Sees Higher 4Q Rev
marketwatch.com - January 6 at 5:35 PM
msn.com logoDaewoong Pharmaceutical signs deal to research on mRNA treatment with U.S. biotech firm
msn.com - January 4 at 11:17 PM
yahoo.com logo$12 Billion Worldwide Oncology Biosimilars Industry to 2027 - Players Include Biocon, Celltrion, Dr. Reddy's Laboratories and Intas Pharmaceuticals
yahoo.com - January 3 at 10:27 AM
benzinga.com logoAnalyst Expectations for Ultragenyx Pharmaceutical's Future
benzinga.com - December 30 at 12:11 PM
marketwatch.com logoRegeneron Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
marketwatch.com - December 15 at 6:07 PM
marketwatch.com logoInovio Pharmaceuticals Inc. stock falls Thursday, underperforms market
marketwatch.com - December 15 at 6:07 PM
marketwatch.com logoStocks to Watch: Vallon Pharmaceuticals, Icosavax, Kaspien Holdings
marketwatch.com - December 13 at 9:05 PM
marketwatch.com logoHome Diagnostics for Urinary Tract Infection Market 2023 : Future Demand, Emerging Trends and Latest Technology, Forecast Research Report 2028
marketwatch.com - November 25 at 6:33 PM
nasdaq.com logoXenon Pharmaceuticals Inc. (NASDAQ:XENE) insiders sold US$9.2m worth of stock, possibly signalling a downtrend
nasdaq.com - October 9 at 2:12 PM
Get Innovus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for INNVD and its competitors with MarketBeat's FREE daily newsletter.



INNVD Media Mentions By Week

INNVD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

INNVD
News Sentiment

0.00

0.68

Average
Medical
News Sentiment

INNVD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

INNVD Articles
This Week

1

1

INNVD Articles
Average Week

Get Innovus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for INNVD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:INNVD) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -